The challenge of evaluating annual mammography screening for young women with a family history of breast cancer

It has been recommended that women aged 40–49 years with a significant family history of breast cancer should be offered annual mammography screening (http://www.nice.org.uk). An observational study known as FH01 (http://www.screeningservices.org/btw/fh01/index.asp) is evaluating this policy in a cohort of 6000 women at moderately increased risk of breast cancer due to family history. The main aims are to assess the likely impact on breast cancer mortality and cost-effectiveness. Measuring these outcomes is challenging in an environment where a randomized trial is not feasible and there is no natural comparison group. In this paper, we present some approaches to estimating effectiveness and the planned analyses. These involve comparison of disease stage and likely consequent breast cancer mortality in the cohort offered screening with that estimated in the absence of screening. The estimation uses observed outcomes in external populations and estimated outcomes for the hypothetical situation where screening had not taken place.

[1]  V. Vogel,et al.  Recognition and management of hereditary breast cancer syndromes. , 2004, The oncologist.

[2]  S. Duffy,et al.  [Detection of cancer, sensitivity of the test and sensitivity of the screening program]. , 1998, Revue d'epidemiologie et de sante publique.

[3]  L. Tabár,et al.  Markov models of breast tumor progression: some age-specific results. , 1997, Journal of the National Cancer Institute. Monographs.

[4]  Sweden.,et al.  Breast-cancer screening with mammography in women aged 40–49 years , 1996 .

[5]  L. Tabár,et al.  Update of the Swedish two-county program of mammographic screening for breast cancer. , 1992, Radiologic clinics of North America.

[6]  Rhian Gabe,et al.  The randomized trials of breast cancer screening: what have we learned? , 2004, Radiologic clinics of North America.

[7]  S. Moss,et al.  Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures , 2005, British Journal of Cancer.

[8]  L. Tabár,et al.  Evaluation by Markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in Sweden. , 1998, Journal of epidemiology and community health.

[9]  L. Tabár,et al.  Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer , 2005, Breast Cancer Research.

[10]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[11]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[12]  J. Cuzick.  Aromatase inhibitors in prevention--data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study). , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[13]  S. Duffy,et al.  Initial results of a study into the effectiveness of breast cancer screening in a population identified to be at high risk. , 2001, Revue d'epidemiologie et de sante publique.

[14]  A Howell,et al.  Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.

[15]  Stephen W. Duffy,et al.  Dépistage des cancers, sensibilité du test et sensibilité du programme de dépistage. , 1998 .

[16]  N. Day,et al.  Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer. , 2001, Journal of epidemiology and biostatistics.

[17]  C. Axelsson,et al.  The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG) , 2004, Breast Cancer Research and Treatment.